A Study to Evaluate SHR-1210 in Subjects With Advanced HCC

Clinical trial NCT02989922 · COMPLETED

Trial details

NCT number: NCT02989922
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Non-Resectable

Start date: 2016-11-15
Primary completion: 2020-03-03
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.